Status:
RECRUITING
Analgesic Effect of Infraspinatus-teres Minor Block for Pre-emptive Analgesia in Patients Undergoing Shoulder Surgeries.
Lead Sponsor:
Zagazig University
Conditions:
Preemptive Analgesia
Eligibility:
All Genders
21-65 years
Phase:
NA
Brief Summary
The aim of the study to evaluate the efficacy of the infraspinatus-teres minor (ITM) block in improving pre-emptive analgesia, reducing opioid consumption, and enhancing the overall analgesic effect i...
Detailed Description
To compare between infraspinatus-teres minor versus control group (GA): 1. To measure analgesic parameters including: the total amount of rescue analgesic consumption (morphine) in the first 24 hours...
Eligibility Criteria
Inclusion
- • Patients' acceptance.
- Age: Adults aged 21-65 years old.
- BMI: 25-30 kg/m2
- Sex: both sexes (males or females).
- Patients undergoing unilateral shoulder surgey under general anesthesia.
- ASA (American Society of Anesthesiologists) physical status classification I to II.
- Duration of the surgery \< 3hours.
Exclusion
- • Patients with contraindications to regional anesthesia (e.g. local or systemic infections, or severe neurological or muscular or bleeding disorders or patient on anticoagulant).
- Allergy to study medications: bupivacaine or dexamethasone, or dexmedetomidine
- Patients with severe cardiovascular, respiratory, renal, or hepatic diseases, uncontrolled diabetes , or those undergoing chronic opioid therapy.
- Psychiatric disorders that hinder informed consent or study participation.
- history of neurological diseases or conditions that would affect the efficacy of nerve blocks (e.g., neuropathy, spinal cord injury, or history of severe muscle weakness).
- Patients with nerve injury or disease around the shoulder joint, including thoracic outlet syndrome, Multiple sclerosis, cervical disc disease with ipsilateral radiculopathy, or patients with abnormal sensory or motor function of the upper limb.
Key Trial Info
Start Date :
June 9 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 30 2026
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06999460
Start Date
June 9 2025
End Date
January 30 2026
Last Update
June 12 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculity of medicine, Zagazig university, Zagazig
Zagazig, Egypt, Egypt
2
Faculty of human medicine, Zagazig university, Zagazig
Zagazig, Egypt